UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial

The lancet oncology, 2022-01, Vol.23 (1), p.91-103

2022

Volltextzugriff (PDF)

Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis

PloS one, 2016-06, Vol.11 (6), p.e0158156

2016

Volltextzugriff (PDF)

Variable selection methods for predicting clinical outcomes following allogeneic hematopoietic cell transplantation

Scientific reports, 2021-02, Vol.11 (1), p.3230-3230, Article 3230

2021

Volltextzugriff (PDF)

Ezh2 phosphorylation state determines its capacity to maintain CD8 + T memory precursors for antitumor immunity

Nature communications, 2017-12, Vol.8 (1), p.2125-14, Article 2125

2017

Volltextzugriff (PDF)

Gastrointestinal toxicity of high-dose melphalan in autologous hematopoietic stem cell transplantation: identification of risk factors and a benchmark for experimental therapies

Annals of hematology, 2021-07, Vol.100 (7), p.1863-1870

2021

Volltextzugriff (PDF)

Current and Future Role of Medical Imaging in Guiding the Management of Patients With Relapsed and Refractory Non-Hodgkin Lymphoma Treated With CAR T-Cell Therapy

Frontiers in oncology, 2021-05, Vol.11 (16), p.664688-664688

2021

Volltextzugriff (PDF)

Revving the CAR – Combination strategies to enhance CAR T cell effectiveness

Blood reviews, 2021-01, Vol.45, p.100695-100695, Article 100695

2021

Volltextzugriff (PDF)

Peripheral blood stem cell grafts in allogeneic hematopoietic cell transplantation: It is not all about the CD34+ cell dose

Transfusion and apheresis science, 2021-02, Vol.60 (1), p.103081-103081, Article 103081

Reshef, Ran

2021

Volltextzugriff (PDF)

Posttransplant Lymphoproliferative Disorder in Solid Organ and Hematopoietic Stem Cell Transplantation

Clinics in chest medicine, 2017-12, Vol.38 (4), p.771-783

2017

Volltextzugriff (PDF)

Post-transplant lymphoproliferative disorder after lung transplantation: A review of 35 cases

The Journal of heart and lung transplantation, 2012-03, Vol.31 (3), p.296-304

2012

Volltextzugriff (PDF)

Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide

Blood advances, 2018-02, Vol.2 (3), p.299-307

2018

Volltextzugriff (PDF)

682 Trial in progress: phase 1 trial of TSC-100 and TSC-101, engineered T-cell therapies targeting minor histocompatibility antigens to eliminate residual disease after hematopoietic cell transplantation

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A774-A774

2023

Volltextzugriff (PDF)

P1390: NEW AND UPDATED RESULTS FROM A MULTICENTER OPEN‐LABEL GLOBAL PHASE3 STUDY OF TAB‐CEL FOR EBV+PTLD FOLLOWING HCT OR SOT AFTER FAILURE OF RITUXIMAB OR RITUXIMAB+CHEMOTHERAPY (ALLELE)

HemaSphere, 2023-08, Vol.7 (S3), p.e0490265-n/a

2023

Volltextzugriff (PDF)

TGM4: an immunogenic prostate-restricted antigen

Journal for immunotherapy of cancer, 2021-06, Vol.9 (6), p.e001649

2021

Volltextzugriff (PDF)

P1107: ZUMA‐22: A PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD‐OF‐CARE THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA

HemaSphere, 2023-08, Vol.7 (S3), p.e6350662-n/a

2023

Volltextzugriff (PDF)

168 A novel prostate-restricted tumor-associated antigen: a potential therapeutic target

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A101-A101

2020

Volltextzugriff (PDF)

Improved accuracy of acute graft-versus-host disease staging among multiple centers

Best practice & research. Clinical haematology, 2014-09, Vol.27 (3), p.283-287

2014

Volltextzugriff (PDF)

Arginine uptake is attenuated, through post-translational regulation of cationic amino acid transporter-1, in hyperlipidemic rats

Atherosclerosis, 2007-10, Vol.194 (2), p.357-363

2007

Volltextzugriff (PDF)

Reduced early mortality with Daratumumab‐based frontline therapy in AL amyloidosis: A retrospective cohort study

American journal of hematology, 2024-03, Vol.99 (3), p.477-479

2024

Volltextzugriff (PDF)

Chimeric antigen receptor T cells for treatment of transformed Waldenström macroglobulinemia

Leukemia & lymphoma, 2020-01, Vol.61 (2), p.465-468

2020

Volltextzugriff (PDF)

NCMP-02. NEUROTOXICITY RELATED TO CAR T-CELL THERAPY IN PATIENTS WITH SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi147-vi147

2021

Volltextzugriff (PDF)

Improved serologic responses to DTaP over Tdap vaccination in adult hematopoietic cell transplant recipients

European journal of haematology, 2023-09, Vol.111 (3), p.499-505

2023

Volltextzugriff (PDF)

Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203)

The Lancet. Haematology, 2019-03, Vol.6 (3), p.e132-e143

2019

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Aktive Filter

KollektionNUS Single-Journal Subscriptions

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(110)
Mit Volltextzugriff
(103)

Publikationsform

Sprache

Englisch
(112)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(54)
Life Sciences & Biomedicine
(48)
Humans
(32)
Hematology
(30)
Transplantation
(21)
Male
(17)
Female
(14)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(12)
Middle Aged
(11)
Adult
(10)
Aged
(10)
Oncology
(10)
Immunology
(9)
Animals
(8)
Biomarkers
(8)
Graft Vs Host Disease - Etiology
(8)
Retrospective Studies
(8)
Graft Vs Host Disease - Diagnosis
(7)
Immunotherapy
(7)
Stem Cell Transplantation
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial

Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis

Variable selection methods for predicting clinical outcomes following allogeneic hematopoietic cell transplantation

Ezh2 phosphorylation state determines its capacity to maintain CD8 + T memory precursors for antitumor immunity

Gastrointestinal toxicity of high-dose melphalan in autologous hematopoietic stem cell transplantation: identification of risk factors and a benchmark for experimental therapies

Current and Future Role of Medical Imaging in Guiding the Management of Patients With Relapsed and Refractory Non-Hodgkin Lymphoma Treated With CAR T-Cell Therapy

Disease risk and GVHD biomarkers can stratify patients for risk of relapse and nonrelapse mortality post hematopoietic cell transplant

Revving the CAR – Combination strategies to enhance CAR T cell effectiveness

Peripheral blood stem cell grafts in allogeneic hematopoietic cell transplantation: It is not all about the CD34+ cell dose

Posttransplant Lymphoproliferative Disorder in Solid Organ and Hematopoietic Stem Cell Transplantation

Post-transplant lymphoproliferative disorder after lung transplantation: A review of 35 cases

Effect of donor characteristics on haploidentical transplantation with posttransplantation cyclophosphamide

682 Trial in progress: phase 1 trial of TSC-100 and TSC-101, engineered T-cell therapies targeting minor histocompatibility antigens to eliminate residual disease after hematopoietic cell transplantation

P1390: NEW AND UPDATED RESULTS FROM A MULTICENTER OPEN‐LABEL GLOBAL PHASE3 STUDY OF TAB‐CEL FOR EBV+PTLD FOLLOWING HCT OR SOT AFTER FAILURE OF RITUXIMAB OR RITUXIMAB+CHEMOTHERAPY (ALLELE)

TGM4: an immunogenic prostate-restricted antigen

P1107: ZUMA‐22: A PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD‐OF‐CARE THERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY FOLLICULAR LYMPHOMA

168 A novel prostate-restricted tumor-associated antigen: a potential therapeutic target

Improved accuracy of acute graft-versus-host disease staging among multiple centers

Arginine uptake is attenuated, through post-translational regulation of cationic amino acid transporter-1, in hyperlipidemic rats

Reduced early mortality with Daratumumab‐based frontline therapy in AL amyloidosis: A retrospective cohort study

Tabelecleucel for allogeneic haematopoietic stem-cell or solid organ transplant recipients with Epstein–Barr virus-positive post-transplant lymphoproliferative disease after failure of rituximab or rituximab and chemotherapy (ALLELE): a phase 3, multicentre, open-label trial

Chimeric antigen receptor T cells for treatment of transformed Waldenström macroglobulinemia

NCMP-02. NEUROTOXICITY RELATED TO CAR T-CELL THERAPY IN PATIENTS WITH SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA

Improved serologic responses to DTaP over Tdap vaccination in adult hematopoietic cell transplant recipients

Aktive Filter

Suchergebnisse filtern